Curtana Pharmaceuticals
0 followers
Curtana Pharmaceuticals is a privately-held, preclinical-stage biopharmaceutical company developing first-in-class, small molecule therapeutics that are highly specific for cancer stem cells in the central nervous system (CNS) for the treatment of glioblastoma (GBM) and other brain cancers.
Org chart
Gregory Stein
Collapse
David M. Weiner
Chief Medical Officer
Michelle Rose
VP, Regulatory Affairs
Lawrence J. Trost
VP, Toxicology & Nonclinical Development
Mark Sorenson
Head, CMC Development
Daniel Pertschuk
Consultant, Clinical Development
Fabio Tucci
Co-founder
